Malignant Head and Neck Mucosal Neoplasm

Malignant Head and Neck Mucosal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

466 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 163
Recruiting: 80
Ph III recruiting: 9
Growth YoY: +33.3%
Industry share: 7%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (63)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07028918	A Prospective Single-Arm Study（NCLDR）(NCLDR)	not yet recruiting	Early Phase 1	35	Qilu Hospital of Shandong UniversityOTHER	0	Jun 19, 2025	clinicaltrials

Data updated 22 days agoSource updated Jun 19, 2025source: clinicaltrials